insider24.ch
Back to the feed

Shareholding disclosure

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC

inSanthera Pharmaceuticals Holding AG

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

30.09.2021

Transaction

24.09.2021

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL9S00093

Beneficial owner

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC

Declared address

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC, New York, NY 10022

Santhera Pharmaceuticals Holding AG is listed on the SIX Swiss Exchange. The shares outstanding has increased to 46,470,235 shares, resulting in an ownership percentage of less than 3%.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open